Brunet J, Choucha Z, Gransagne M, Tabbal H, et al. A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model. J Virol 2024 Apr 2:e0169323. doi: 10.1128/jvi.01693.
PMID: 38563763